Apolipoprotein E (Apo E) gene polymorphism in the Bangladeshi population and its comparison with other Asian populations

Journal of Medical Sciences

Volumn 6, Issue 2, 2006, Pages 203-208

  Ahmed, Minhaz Uddin ^a   Akhteruzzaman, Sharif ^a  

^a UNIVERSITY OF DHAKA   (Bangladesh)

Author keywords

Allele; Apo E; Genotype; Polymorphism; Restriction isotyping

Indexed keywords

AMINO ACID; APOLIPOPROTEIN E; LIGAND; LIPOPROTEIN; RESTRICTION ENDONUCLEASE;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; ASIAN; BANGLADESH; CHI SQUARE TEST; CLUSTER ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDIAN; JAPAN; MALE; POPULATION RESEARCH; PROTEIN FUNCTION; SINGAPORE;

EID: 33645341966     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2006.203.208     Document Type: Article

References (31)

1. Asakawa, J., N. Takahashi, B.B. Rosenblum and J.V. Neel, 1985, Two-dimensional gel studies of genetic variation in the plasma proteins of Amerindians and Japanese. Hum. Genet., 70: 222-230.
2. Bao-Sheng, C., T. Rbnnemaa, G. Dahlen and T. Nikkari, 1990. Apo-E phenotypes in nine populations. Am. J. Hum. Genet., 119: 49: 338-349.
3. Boerwinkle, E., S. Visvikis, D. Welsh, J. Steinmertz, S.M. Hanash and F. Sing, 1989. The use of measured genotype information in the analysis of quantitative phenotype in man. II. The role of apolipoprotein E polymorphism in determining levels, variability and covariability of cholesterol, betalipoproteins and triglycerides in a sample of unrelated individuals. Am. J. Hum. Genet., 27: 567-582.
4. Davignon, J., 1993. Apolipoprotein E polymorphism and atherosclerosis In: GVR Born, CJ Schwartz (Eds.): New Horizons in Coronary Heart Disease. Current Science, 5: 5.1-5.21.
5. Davignon, J. and S. Petkar, 1998. Apolipoprotein E polymorphism and atheroscleros. Atherosclerosis, 8: 1-21.
6. Dhawan, J. and S. Petkar, 1998. Epidemiology of coronary artery disease in South Asians. Cur. Sci., 74: 1060-1073.
7. Ehnholm, C., M. Lukka, T. Kuusi, E. Nikkila and G. Utermann, 1986. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J. Lipid Res., 27: 227-235.
8. Eichner, J.E., S.T. Dunn, G. Perveen, D.M. Thompson, K.E. Stwart, B.C. Stroehia, 2002. Apolipoprotein E polymorphism and cardiovascular disease. A HuGE Review. Am. J. Epidemiol., 155: 487-495.
9. Emi, M., L.L. Wu, M.A. Robertson, R.L. Myers, R.R. Hegele, R.R. Williams, R. White and J.M. Lalouel, 1988. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics, 3: 373-379.
10. Gerdes, L.U., C. Gerdes, K. Kervinen, M. Savolainen, I.C. Klausen, P.S. Hansen, Y.A. Kesllniemi and O. Faergeman, 2000. The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction: a substudy of the Scandinavian simvastatin survival study. Circulation, 101: 1366-1371.
11. Gustincich, S ., G. Manfiolett, G. Del Sal, C. Schneider and P. Carninci, 1991. A fast method for high-quality genomic DNA extraction. Bio Tech., 11: 298-302.
12. Hallman, D.M., E. Boerwinkle, N. Saba, C. Sandholzer, H.J. Menzel and G. Utermann, 1991. The apolipoprotein E polymorphism: a comparision of allele frequencies and effects in nine population. Am. J. Hum. Genet., 49: 338-349.
13. Hixson, J.E. and D.T. Vernier, 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res., 31: 545-548.
14. Horita K,, M. Eto, M. Saito, H. Nakata, Y. Iwashima, H. Ito, M. Takahashi, A. Kondo, A. Morikawa and I. Makino, 1993. Effects of apolipoprotein E polymorphism on plasma lipoprotein(a) levels. Artery, 20: 324-336.
15. Hülya, Y., I. Turgay, A. Bedia and A. Makbule, 2001. Is ε4 allele of apolipoprotein E associated with more sever end-organ damage in essential hypertension? Cell Biochem. Funct., 19: 191-195.
16. Kathy, L.K., L.R.K. Sharon, R.E. Ferrell, T.T. Stephen, B. Eric and F. S. Charles, 2001. Genome-Wide Linkage Analysis Reveals Evidence of Multiple Regions That Influence Variation in Plasma Lipid and Apolipoprotein Levels Associated With Risk of Coronary Heart Disease. Arterioscler. Thromb. Vasc. Biol., 21: 971.
17. Kobori, S., N. Nakamura, H. Uzawa and M. Shichiri, 1988. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan. Atherosclerosis., 69: 81-88.
18. Mahley, R.W., 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science., 240: 622-630.
19. Miida T. 1990. Apolipoprotein E phenotypes in patients with coronary artery disease. Tohoku J. Exp. Med., 160: 177-187.
20. Rall, S.C., K.H. Weisgraber and R.W. Mahley, 1982. Human apolipoprotein E: the complete amino acid sequence. J. Biol. Chem., 257: 4171-4178.
21. Sano, R., R. Abe, S. Oikawa, Y. Fujii, S.Hori, N. Suzuki, T. Toyota and Y. Goto, 1988. Apolipoprotein E phenotypes of normo- and hyperlipoproteinemia in Japanese. Tohoku J. Exp. Med., 154: 297-303.
22. Scott, J., T.J. Knott,. D.J. Shaw, D.J. Brook, 1985. Localization of genes encoding apolipoprotein CI, CII and E to the p13 ->cen region of the human chromosome 19. Hum. Genet., 71: 144-146.
23. Sing, C.F. and P.P. Moll, 1989. Genetics of variability of CHD risk. Int. J. Epidemiol., 18 (Suppl. I): S183-S195.
24. Sokal, R.R. and P.H.A. Sneath, 1963. Principles of Numerical Taxonomy. San Francisco: WH Freeman, pp: 359-361.
25. Tsuchiya S, Y. Yamanouchi, M. Onuki, K. Yamakawa, R. Miyazaki, T. Taya, I. Kondo, M. Ohnuki and H. Hamaguchi, 1985. Frequencies of apolipoproteins E5 and E7 in apparently healthy Japanese. Jinrui Idengaku Zasshi., 30: 271-278.
26. Utermann G., 1987. Apolipoprotein E polymorphism in health and disease. Am. Heart J., 113: 433-440.
27. Venkatraman, R., R. Chengal and R.E. Ferrell, 2001. Apolipoprotein E polymorphism among the Indian populations and its comparision with other Asian populations. Ind. J. Hum. Genet., 1: 123-128.
28. Wang, K.Q., J.L He and Y.H Xie, 1987. Studies on human apolipoprotein E genetic isoforms and their phenotypes among the Chinese population. Proc. Chin. Acad. Med. Sci. Peking Union Med. Coll., 2: 133-139.
29. Weisgraber, K.H., S.C. Rall and R.W. Mahley, 1981. Human E apoprotein heterogeity: cysteine-arginine interchanges in the amino acid sequence of the apo E isoforms. Biol. Chem., 256: 9077-9083.
30. Weisgraber, K.H., 1994. Apolipoprotein E: Structure function relationships. Adv. Protein Chem., 45: 249-303.
31. Yamamura T., S. Tajima, Y. Miyake, S. Nomura, A. Yamamoto, K. Haze and K. Hiramori, 1990. Hyperlipoprotenemia a risk factor for ischemic heart disease. Jpn. Circ. J., 54: 448-456.